Showing 41-50 of 1614 results for "".
Modern Management of Vitreous Opacities: Examination and Referral
https://modernod.com/podcasts/the-mod-pod/vitreous-opacities-examination-and-referral/36820/Which elements of examination must optometrists perfect in order to provide an effective referral for patients with vitreous opacities? On this second episode of the miniseries “Modern Management of Vitreous Opacities,” the panel comprised of Walt Whitley, OD, MBA; Alison Early, MD; John Kitchens, MReferral Network Breakdown
https://modernod.com/mod-issues/2019-mar/referral-network-breakdown/39052/The two most common types of communication issues between collaborating ODs and MDs and how to set them straight.[Genetics and Eyecare Today] How CXL and Genetic Testing Fit Into the Keratoconus Game Plan
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-how-cxl-and-genetic-testing-fit-into-the-keratoconus-game-plan/36816/The season finale of The MOD Pod’s mini series Genetics and Eyecare Today features Nicole Fram, MD, and Melissa Barnett, OD, FAAO, FSLS, FBCLA. Dr. Fram explains what corneal collagen crosslinking is and shares her protocol for administering the therapy. She also describes the typical situation in wFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesAlcon Acquires LumiThera
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-lumithera/37092/Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoicesAn Interview With the Inventor of Rinsada
https://modernod.com/podcasts/to-the-point/an-interview-with-the-inventor-of-rinsada/36934/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by retina specialist Srinivas Kondapalli, MD, who developed the Rinsada Irrigating Lid Retractor, which effectively cleanses the conjunctival fornix, palpebral conjunctiva, and bulbar conjunctiva.Case Studies in Treating Ocular Surface Disease: Season 5
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-5/36830/The newest season includes a new expert panel featuring Jackie Garlich, OD, FAAO; Justin Schweitzer, OD, FAAO; and William B. Trattler, MD, as they share unique cases of meibomian gland dysfunction, neurotrophic keratitis, and the impact of ocular surface disease on cataract surgery planning.Case Studies in Treating Ocular Surface Disease: Season 4
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-4/36826/Don’t miss this season in which our new expert panel of Leslie O’Dell, OD, FAAO; Emilie Seitz, OD; and Ivan Mac, MD, MBA, discuss unique and challenging cases involving ocular surface disease and dry eye.Targeted, Specific, Customized Care for Patients With Dry Eye
https://modernod.com/videos/eye-care-insiders/eci-december-2021-video/37307/While at the recent American Academy of Optometry meeting in Boston, Massachusetts, Joseph Allen, OD, FAAO, caught up with “dry eye master” Laura Periman, MD, to find out what treatments she typically recommends for her dry eye patients as well as what future innovations she’s excited about.How are innovations in genetic testing affecting eyecare?
https://modernod.com/podcasts/the-mod-pod/genetics-narrowing-the-treatment-tree/36802/In the first episode of the Genetics and Eyecare Today podcast mini-series, Elizabeth Yeu, MD, and John Gelles, OD take a broad look at genetic testing and how it relates to eyecare. The pair discuss how recent innovations in genetic testing have affected screening, diagnosis, and care of patients w